Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Breast Cancer Therapy

Taxanes added to chemotherapy are unlikely to produce chemotherapy-induced amenorrhea

According to a scientists from the United States, "Twenty-five percent of all women with breast carcinoma are pre-menopausal and are at risk for chemotherapy-induced menopause with long-term side effects. Although there is considerable documentation of the rates of chemotherapy-induced amenorrhea with classic adjuvant regimens, there are inadequate data that address the impact of taxanes on menstrual function in this setting."

M.N. Fornier and colleagues explained, "The objective of this analysis was to determine the incidence of long-term amenorrhea...

• View Other Issues of Women's Health Weekly
  
• View Other NewsRx Publications